- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04392856
Transdiagnostic Treatment of Emotional Disorders for Women in a Homeless Situation (UPHW)
Study Overview
Status
Conditions
Detailed Description
The European Strategy for the Homeless People states that homelessness is the most extreme form of poverty and exclusion, which violates human dignity and poses a risk to health and life. Women constitute a particularly vulnerable subgroup among homeless people. Women living homeless show significant deterioration in their psychological welfare and mental health, which, among other aspects, is an obstacle in the access to care resources and inclusion processes.
There is a growing interest in the effectiveness and efficiency of intervention techniques to address mental health problems. The high comorbidity between mental health disorders, and especially emotional disorders, has promoted the development and consolidation of a transdiagnostic perspective. This perspective raises the existence of common mechanisms involved in the maintenance of different disorders, so that there would be a preamble to cognitive and/or behavioral processes shared by various psychological disorders. The design of a transdiagnostic treatment strategy allows a more inclusive approach to mental health and facilitates the design of similar treatment programs applicable to a wide range of mental disorders. Therefore, the transdiagnostic treatment could be a feasible and effective alternative to address some of the most common problems in mental health among women in a homeless situation. This approach could be useful to improve a diversity of symptoms in the own context of homeless living women and facilitate a systematic evaluation of its effectiveness.
The overall objective of this project is the development of a feasible and effective intervention adapted to the needs of women in a homeless situation and the service resources where they are attended. Moreover, the project aims to compare the group versus individual delivery of the UP among women in a homeless situation. This research is based on the hypothesis that the UP adaptation, both in group and individual delivery, will be effective in reducing anxiety and depression symptoms, decreasing negative affect and increasing psychological well-being, health state, positive affect, social support and quality of life. Strengths but also barriers and difficulties encountered in each format of intervention will be examined. This knowledge will be key to develop specific and adapted materials that enable effective interventions practices in the services resources for homeless people.
The UP intervention will consist of 12 weekly sessions lasting an hour and a half, applied in different centers for homeless people in Madrid. There will be several assessment moments: before the intervention, twelve intersession assessments (i.e., one per session), after the intervention, and 3 months, 6 months and 9 months follow-ups. The psychological intervention will be carried out by therapists with a background in psychology.
With this research it is expected to achieve results with impact at the technical level (in the design of effective interventions for psychological treatment of women in a homeless situation), on a scientific level (expanding knowledge about the effectiveness of intervention programs for women in social exclusion situations), and, especially, at the social level (affecting the quality of life and the processes of social inclusion of women in a homeless situation).
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Madrid, Spain, 28223
- Faculty of Psychology. Complutense University of Madrid
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Being a woman.
- Being aged over 18 years old.
- Providing written, informed consent.
- The participant is fluent in the language in which the treatment and evaluation are performed (i.e. Spanish).
- Being able to attend to the evaluation and treatment sessions
- Having access to the shelters where the intervention will be carried out.
Exclusion Criteria:
- Being diagnosed with a severe mental disorder in active phase (i.e. schizophrenia, bipolar disorder or an organic mental disorder).
- Being diagnosed a severe cognitive deterioration.
- Being under alcohol or substance effects when the pre-assessment is carried out.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Unified Protocol Transdiagnostic Treatment Emotional Disorders
An adaptation of the Unified Protocol for Transdiagnostic Treatment of Emotional Disorders (UP) to women in a homeless situation will be implemented in public shelters setting in Madrid, Spain. The UP adaptation is an intervention based protocol for emotional disorders, consisted of 12 treatment sessions of one and a half hours of duration each, at a rate of one per week. |
The Spanish Version of the Unified Protocol for the Transdiagnostic Treatment of Emotional Disorders for Homeless Women.
The protocol contains five modules: (1) mindful emotion awareness, (2) cognitive flexibility, (3) countering emotional behaviors, (4) recognizing and confronting physical sensations, and (5) emotion exposures.
This adaptation of Unified Protocol is organized in twelve sessions: Emotional disorders and emotional regulation; Motivation for change; Understanding the role of emotions; Mindful emotion awareness, Cognitive flexibility, Understanding and confronting physical sensations, Countering emotional behaviors, Emotional avoidance, Emotion exposure; Achievement recognition and look to the future; and Relapse prevention and closure.
|
|
Other: Waitlist Control condition
The participants assigned to the waitlist control condition will not immediately receive the intervention.
They will wait for 3 months, which is the duration of the intervention in the experimental group.
After that time, they will be offered the same psychological treatment as those assigned to the UP (experimental condition).
|
The Spanish Version of the Unified Protocol for the Transdiagnostic Treatment of Emotional Disorders for Homeless Women.
The protocol contains five modules: (1) mindful emotion awareness, (2) cognitive flexibility, (3) countering emotional behaviors, (4) recognizing and confronting physical sensations, and (5) emotion exposures.
This adaptation of Unified Protocol is organized in twelve sessions: Emotional disorders and emotional regulation; Motivation for change; Understanding the role of emotions; Mindful emotion awareness, Cognitive flexibility, Understanding and confronting physical sensations, Countering emotional behaviors, Emotional avoidance, Emotion exposure; Achievement recognition and look to the future; and Relapse prevention and closure.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in the Beck Depression Inventory (BDI-II) (Beck, Steer, & Brown, 1990); Spanish adaptation (Sanz, Navarro, & Vázquez, 2003) at pre, post intervention and at 3, 6 and 9 month follow-ups.
Time Frame: Up to 9 months
|
The BDI-II is a 21-item self-report measure designed to assess depression severity.
Each item is rated from 0 to 3 with a total score of a maximum of 63 points.
The Spanish version has shown good internal consistency (α = 0.86).
|
Up to 9 months
|
|
Change in the Beck Anxiety Inventory (BAI) (Beck, & Steer, 1993); Spanish adaptation (Magán, Sanz, & García-Vera, 2008) at pre, post intervention and at 3, 6 and 9 month follow-ups.
Time Frame: Up to 9 months
|
The BAI is a 21-item self-report measure designed to assess anxiety severity.
Each item has a 4-point severity scale (e.g., not at all, mildly, moderately, and severely), addressing symptoms experienced during the past week.
The internal consistency of the Spanish version has been found to range from .85 to .94.
|
Up to 9 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Positive and Negative Affect Schedule (PANAS) (Watson, Clarck, & Tellegen, 1988); Spanish adaptation (López-Gómez, Hervás, & Vázquez, 2015) at pre, post intervention and at 3, 6 and 9 month follow-ups
Time Frame: Up to 9 months
|
The PANAS is a 20-item self-report measure designed to assess negative and positive affect in the last week.
Each item has a 5-point severity scale (e.g., not at all, mildly, moderately, quite a lot, and severely) with a total score from 20 to 100.
The internal consistency of the Spanish version was .92 for positive affect subscale and .88 for negative affect subscale.
|
Up to 9 months
|
|
Change in the Pemberton Happiness Index (PHI) (Hervás & Vázquez, 2013) at pre, post intervention and at 3, 6 and 9 month follow-ups
Time Frame: Up to 9 months
|
The PHI is a 21-item measure designed to assess integrative well-being using a scale from 0 (fully disagree) to 10 (fully agree) in the first 11 items and dichotomy answers (yes/no) in the last 10 items.
It includes two subscales: remember well-being (general, hedonic, eudaimonic, and social well-being) and experienced well-being.
Cronbach´s alpha of Spanish version was .84.
|
Up to 9 months
|
|
Change in the Short-Form Health Survey Health Questionnaire (SF-12) (Ware, Kosinski, & Keller, 1996); Spanish adaptation (Vilagut et al., 2008) at pre, post intervention and at 3, 6 and 9 month follow-ups
Time Frame: Up to 9 months
|
The SF-12 is a generic health status instrument with 12 items, and eight subscales (physical functioning, role physical, bodily pain, general health, vitality, social functioning, role emotional and mental health).
These eight subscales can be combined into two scores for physical health (PH) and mental health (MH), and a total score, ranged from 0 to 100, where higher scores reflect better self-reported health.
The internal consistency of the Spanish version was α = .85
for PH and α = .78
for MH.
|
Up to 9 months
|
|
Change in the Social Support Questionnaire (SSQ) (Sarason, Sarason, Shearin, & Pierce, 1987); Spanish adaptation (Martínez-López et al., 2014) at pre, post intervention and at 3, 6 and 9 month follow-ups.
Time Frame: Up to 9 months
|
The SSQ is a 6 items measure of social support.
It includes two scales: number and satisfaction with social support (on a scale ranging from 1 to 9).
The Spanish version has shown good internal consistency for both dimensions (α = 0.90 and α = 0.93, respectively).
|
Up to 9 months
|
|
Change in the Satisfaction with Life Domain Scale (SLDS) (Baker e Intagliatta, 1982); Spanish version by Muñoz, Panadero, & Rodríguez (2010) at pre, post intervention and at 3, 6 and 9 month follow-ups.
Time Frame: Up to 9 months
|
This questionnaire was adapted for use in rehabilitation centers for people with mental disorders by Muñoz et al. (2010).
It is a 18-item self-report measure that was designed for assessing their actual satisfaction in various aspects of the life.
An 8-point visual analog scale with faces is used.
|
Up to 9 months
|
|
Overall Depression Severity and Impairment Scale (ODSIS) (Bentley, Gallagher, Carl, Barlow, 2014); Spanish version (Mira et al., 2019) at intersession assessment
Time Frame: Up to 3 months
|
The ODSIS is a 5-item self-report measure that was designed for assessing the frequency and intensity of depression symptoms, the functional impairment related to these depressive symptoms, as well as behavioral avoidance across emotional disorders over the past week.
Response items are coded from 0 to 4 and can be summed to obtain a total score ranging from 0 to 20.
The internal consistency of the Spanish version was between .91 and .94.
|
Up to 3 months
|
|
Overall Anxiety Severity and Impairment Scale (OASIS) (Norman, Cissell, Means-Christensen, & Stein, 2006); Spanish version (González-Robles et al., 2018) at intersession assessment
Time Frame: Up to 3 months
|
The OASIS is a self-report questionnaire designed to evaluate the severity and functional impairment associated with anxiety.
The scale presents five items with a 5-point likert scale ranging from 0 (I didn't feel anxious) to 4 (Constant anxiety).
The total scale score, which ranges from 0 to 20, is obtained by summing all items.
Cronbach's alpha of the Spanish version was 0.86.
|
Up to 3 months
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Alcohol Use Disorders Identification Test (AUDIT) (Saunders et al. 1993); Spanish adaptation (Rubio, Bermejo, Caballero, & Santo Domingo, 1998).
Time Frame: Up to 9 months
|
The AUDIT was developed as a simple screening method for excessive alcohol consumption.
The AUDIT consists of 10 questions about the level of consumption, symptoms of dependence and alcohol-related consequences with a total score of a maximum of 63 points.
The Spanish version reliability coefficient was 0.86.
|
Up to 9 months
|
|
Drug Abuse Screening Test (DAST-10) (Skinner, 1982); Spanish adaptation (Pérez-Gálvez et al., 2010)
Time Frame: Up to 9 months
|
It is one of the instruments more used for detection is the Drug Abuse Screening Test (DAST).
The DAST-10 is a 10 items self-reports with dichotomous response (yes/no).
The Spanish version has shown a high internal consistency (α = 0.89).
|
Up to 9 months
|
Collaborators and Investigators
Investigators
- Principal Investigator: Sonia Panadero, PhD, Complutense University of Madrid
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- FEM2016-75317-R
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Depression
-
Massachusetts General HospitalRecruitingDepression | Depression - Major Depressive Disorder | Depression Chronic | Depression in Adults | Depression Disorders | Depression DisorderUnited States
-
University of California, San FranciscoNational Center for Complementary and Integrative Health (NCCIH)Active, not recruitingDepression Moderate | Depression Mild | Depression, TeenUnited States
-
ProgenaBiomeWithdrawnDepression | Depression, Postpartum | Depression, Anxiety | Depression Moderate | Depression Severe | Clinical Depression | Depression in Remission | Depression, Endogenous | Depression ChronicUnited States
-
Sorlandet Hospital HFUniversity of Oslo; Karolinska Institutet; Australian Catholic University; Helse...RecruitingAnxiety | Anxiety Depression | Depression Anxiety Disorder | Depression - Major Depressive DisorderNorway
-
Washington University School of MedicineCompletedTreatment Resistant Depression | Late Life Depression | Geriatric Depression | Refractory Depression | Therapy-Resistant DepressionUnited States, Canada
-
Lipocine Inc.CompletedDepression, Postpartum | Postnatal Depression | Peripartum Depression | Depression, Post-Partum | Postpartum Depression (PPD) | Post-Natal DepressionUnited States
-
Kintsugi Mindful Wellness, Inc.Sonar Strategies; Vituity PsychiatryActive, not recruitingDepression | Depression Moderate | Depression Severe | Depression MildUnited States
-
Kintsugi Mindful Wellness, Inc.Sonar Strategies; Kolby Walker, DO; Brittany KimbleRecruitingDepression | Depression Moderate | Depression Severe | Depression MildUnited States
-
University of CincinnatiNational Center for Complementary and Integrative Health (NCCIH)RecruitingMild DepressionUnited States
-
Fondation FondaMentalGYNOVNot yet recruitingDepression | Depression in Adults | Depression DisorderFrance
Clinical Trials on Unified Protocol for Transdiagnostic Treatment of Emotional Disorders (UP)
-
Duke UniversityCompletedMisophoniaUnited States
-
University of Los Andes, ColumbiaCompletedEmotional DisorderColombia
-
University of MiamiThe Children's Trust, Miami FLRecruitingDepressive Disorder | Parenting | Anxiety Disorder | Mental Health IssueUnited States
-
Rotherham Doncaster and South Humber NHS Foundation...University of Sheffield; Innovate UK; MindLife UK LtdRecruitingAnxiety | Common Mental Health Problems | Depression DisordersUnited Kingdom
-
Massachusetts General HospitalCompletedAnxiety Disorders | Bipolar DisorderUnited States
-
Jorge Javier Osma LópezHospital General Universitario de Castellón; Hospital Universitario La Plana...Not yet recruitingInfertility | Emotional Disorder | Anxiety DepressionSpain
-
Fundació Sant Joan de DéuParc Sanitari Sant Joan de DéuRecruitingPsychosis | Emotional DysfunctionSpain
-
Boston University Charles River CampusCompletedAnxiety Disorders | Emotional Disorders
-
Instituto de Investigación Sanitaria AragónRecruitingDepressive Disorder | Anxiety Disorders | Emotional Disorder | Post COVID-19 ConditionSpain
-
Jorge Javier Osma LópezUniversidad de Zaragoza; Instituto de Salud Carlos IIINot yet recruiting